ATRC's cryoSPHERE MAX probe cuts freeze times by 50%, advancing Cryo Nerve Block therapy to improve post-op pain relief and reduce opioid dependency risks.

AtriCure (Nasdaq: ATRC) announced today that it has launched the new CryoSphere Max cryoablation probe technology.

AQR Capital Management LLC boosted its stake in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 38.2% in the second ...

InMode (NASDAQ:INMD) shares fell roughly 8% on Tuesday after the medical devices company announced the departure of executives as part of a “global reorganization strategy.” Shakil Lakhani ...

AtriCure (NASDAQ:ATRC – Get Free Report ... Director Maggie Yuen sold 3,500 shares of the business’s stock in a transaction on Thursday, August 15th. The shares were sold at an average ...

An image of a chain link. It symobilizes a website link url. Copy Link US stocks were mixed on Friday, with the Dow Jones closing at a new all-time high while the Nasdaq 100 and S&P 500 traded ...

Super Micro Computer has a 10-for-1 stock split planned for after market close Sept. 30. Companies that decide to split their stock -- increasing share count and decreasing per-share price -- are ...

Investors often lean into valuation ratios to determine what a company’s stock is worth. Why? Such ratios are easy to calculate and easy to find. Price/earnings ratio: A stock’s price divided ...

Chinese stocks were off to the races on Thursday after Chinese leaders gave investors what stimulus measures earlier in the week failed to do: indications that policymakers are finally alarmed ...

Could Nvidia stock reach $200 in the next two years? We think there is a possibility. How? Consider this, just about nine months ago, at the end of December 2023, Nvidia stock was trading at ...

Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ATRC is Buy with a score of 4.89.